Apyx Medical (APYX) EBT Margin Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Apyx Medical | 174.53 Mn | 143.65 Mn | 7.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,001.00 |
| Dec 31, 2025 | 8,308.00 |
| Sep 30, 2025 | 4,940.00 |
| Jun 30, 2025 | 11,146.00 |
| Mar 31, 2025 | 9,348.00 |
| Dec 31, 2024 | 21,840.00 |
| Sep 30, 2024 | 1,483.00 |
| Jun 30, 2024 | 965.00 |
| Mar 31, 2024 | 2,595.00 |
| Dec 31, 2023 | 2,794.00 |
| Sep 30, 2023 | 5,501.00 |
| Jun 30, 2023 | 7,222.00 |
| Mar 31, 2023 | 3,408.00 |
| Dec 31, 2022 | 3,905.00 |
| Sep 30, 2022 | 4,779.00 |
| Jun 30, 2022 | 440.00 |
| Mar 31, 2022 | 5,688.00 |
| Dec 31, 2021 | 7,372.00 |
| Sep 30, 2021 | -2,558.00 |
| Jun 30, 2021 | -2,956.00 |
| Mar 31, 2021 | -3,102.00 |
| Dec 31, 2020 | -1.00 |
| Sep 30, 2020 | -4,369.00 |
| Jun 30, 2020 | -12,332.00 |
| Mar 31, 2020 | -12,304.00 |
| Dec 31, 2019 | -7,879.00 |
| Sep 30, 2019 | 473.00 |
| Jun 30, 2019 | -5,867.00 |
| Mar 31, 2019 | 4,810.00 |
| Dec 31, 2018 | -4,390.00 |
| Sep 30, 2018 | -8,780.00 |
| Jun 30, 2018 | -11,616.00 |
| Mar 31, 2018 | -6,860.00 |
| Dec 31, 2017 | -8,886.00 |
| Sep 30, 2017 | -11,216.00 |
| Jun 30, 2017 | -5,946.00 |
| Mar 31, 2017 | -10,886.00 |
| Dec 31, 2016 | -6,229.00 |
| Sep 30, 2016 | -1,181.00 |
| Jun 30, 2016 | -1,450.00 |
| Mar 31, 2016 | -3,595.00 |